Skip to main content

Advertisement

Table 2 Factors Affecting Complete Eradication of Dysplasia

From: Length of Barrett’s segment predicts failure of eradication in radiofrequency ablation for Barrett’s esophagus: a retrospective cohort study

  All Patientsa Complete Eradication of Dysplasia Incomplete Eradication of Dysplasia  
  107 100.0% 82 76.6% 25 23.4% p-valueb
Patient Characteristics
Race
 White 103 96.3% 80 97.6% 23 92.0% 0.232
 Other 4 3.7% 2 2.4% 2 8.0%
Sex
 Male 93 86.9% 69 84.1% 24 96.0% 0.180
 Female 14 13.1% 13 15.9% 1 4.0%
 Age c64 (58-72) c 64 (57–72) c 66 (59–76) 0.336
 BMI c 29.1 (25.5–32.6) c 30.5 (26.5–33.1) c 27.45 (24.5–30) 0.045
Dysplasia
 HGD 44 41.1% 30 36.6% 14 56.0% 0.084
 LGD 63 58.9% 52 63.4% 11 44.0%
Comorbidities     0.0%    
 GERD 75 70.1% 60 73.2% 15 60.0% 0.208
 Hyperlipidemia 26 24.3% 20 24.4% 6 24.0% 0.968
 Diabetes 25 23.4% 18 22.0% 7 28.0% 0.532
 Hypertension 59 55.1% 40 48.8% 19 76.0% 0.017
History of Tobacco Usage
 Yes 60 56.1% 43 52.4% 17 68.0% 0.350
 No 33 30.8% 28 34.1% 5 20.0%
 Unknown 14 13.1% 11 13.4% 3 12.0%
Endoscopic Treatments Received
 EMR 24 22.4% 18 22.0% 6 24.0% 0.732
Length
 Median, IQR 5 (2–7) 4 (2–7) 6 (2–8) 0.150
 </= 5 cm 64 59.8% 52 63.4% 12 48.0% 0.038
  > 5 cm 43 40.2% 30 36.6% 13 52.0%
Number of RFA’s
 Median, IQR 3 (2–5) 3 (2–5) 4 (2–5) 0.066
  ≤ 3 62 57.9% 52 63.4% 10 40.0% 0.064
  >  3 45 42.1% 30 36.6% 15 60.0%  
  1. aData presented as N (%) or median (IQR)
  2. bp-value ≤0.05 is significant
  3. caverage; not total number of patients